Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

ClinicalTrials.gov ID: NCT00549718

Public ClinicalTrials.gov record NCT00549718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-Controlled, CLinical Trial to Study the Safety and Efficacy of Three Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.

Study identification

NCT ID
NCT00549718
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
489 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2007 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Jun 11, 2014

2007 – 2010

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
K&S Professional Research Services, LLC. Little Rock Arkansas 72201 —
Comprehensive Neuroscience, Inc Cerritos California 90703 —
Clinical Innovations, Inc. Costa Mesa California 92647 —
Collaborative Neuroscience Network Inc.,12772 Valley View Street,Suite 3 Garden Grove California 92645 —
California Clinical Trials Paramount California 90723 —
Pasadena Research Institute Pasadena California 91107 —
California Neuropsychopharmacology,CNRI - Los Angeles LLC,8309 Telegraph Road Pico Rivera California 90660 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Comprehensive Neuroscience, Inc. Washington D.C. District of Columbia 20016 —
Florida Clinical Research Center, LLC Bradenton Florida 34208 —
Segal Institute for Clinical Research, Fidelity Clinical Research, Inc. North Miami Florida 33161 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Alexian Brothers Health System Hoffman Estates Illinois 60169 —
Lake Charles Clinical Trials LLC Lake Charles Louisiana 70601 —
Booker, J. Gary, MD. APMC Shreveport Louisiana 71104 —
Center for Behavioral Health, LLC Rockville Maryland 20850 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
Erie County Medical Center, Corp Buffalo New York 14215 —
CRI Worldwide LLC at Kirkbride Philadelphia Pennsylvania 19139 —
Research Strategies of Memphis, LLC. Memphis Tennessee 38119 —
Future Search Trials of Neurology Austin Texas 78756 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00549718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00549718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →